• alyaza [they/she]@beehaw.orgM
    link
    fedilink
    arrow-up
    8
    ·
    1 year ago

    Pfizer recently announced it would increase the U.S. list price of its patented Covid treatment nirmatrelvir-ritonavir (Paxlovid) to $1,390 for a five-day treatment course. Experts at Harvard University have estimated that the cost of producing a five-day course of nirmatrelvir-ritonavir is $13.

    cool, love that. i think it’s awesome that you can just unilaterally mark up the cost of an essential medicine like this.

  • Erdrick@beehaw.org
    link
    fedilink
    arrow-up
    2
    ·
    edit-2
    1 year ago

    I personally liked the working of “spikes” into the headline.
    I also personally don’t like the price jump.
    I’d love to know what their R&D cost that went into it was though.